- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05761925
The COMA Family Program: A Skills-Based Resiliency Program for Caregivers of Patients With Severe Acute Brain Injuries (COMA-F)
The COMA Family Program: A Skills-Based Resiliency Program for Caregivers of Patients With Severe Acute Brain Injuries (COMA-F)
Study Overview
Detailed Description
The goal of this study is to refine our proposed intervention (COMA-F) through an open pilot. The investigators will deliver an open pilot of the intervention (N=15 caregivers) to evaluate initial feasibility and acceptability using exit interviews and pre-post assessments.
The open pilot will take place at the Massachusetts General Hospital, University of North Carolina School of Medicine, and University of Maryland School of Medicine neurological intensive care units (NICUs) or step-down units using our established methodology successfully implemented during our previous R21 of our Recovering Together study. Study clinicians will deliver 6, 30 minute sessions of the intervention (at bedside or on Zoom, depending on participant preference). All participants will complete measures at baseline, and after completion of program (6 weeks). They will also complete measures of emotional distress weekly. At the completion of the program, participants will engage in a 5-10 minute exit interview where they will provide feedback of the intervention.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02114
- Massachusetts General Hopsital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
Eligible caregivers must be caregivers of patients considered to have severe acute brain injury and be unable to communicate with their loved one or clinical team due to their incapacitated nature. Caregivers must meet the following inclusion criteria:
- Age 18 or older
- English-speaking
Confirmed by the primary clinical team as the primary caregiver for a patient who:
a. Is age 18 or older; b. Has been admitted to the ICU with a severe acute brain injury: i. Ischemic stroke ii. Intracerebral hemorrhage iii. Subarachnoid hemorrhage iv. Traumatic brain injury v. Hypoxic-ischemic encephalopathy; c. In the judgment of the medical team, has had a Glasgow Coma Scale score below 9 while not intubated OR an inability to following meaningful commands while intubated at any point during his or her hospitalization course for greater than 24 consecutive hours, felt to be due to the brain injury itself and not a confounding factor (i.e., sedation, seizures, etc.); d. Is still alive in the ICU at the time that the clinical team approaches the primary caregiver about possible recruitment; e. Has a prognosis for survival of greater than 3 months and does not have a concurrent diagnosis of a terminal illness or injury, as judged by the clinical team.
Exclusion Criteria:
Patient has terminal diagnosis
Caregiver has:
- Lack of access to internet and/or a device with a camera
- Current untreated or unstable severe mental health conditions like bipolar disorder, schizophrenia, or active substance use
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention
Caregivers will participate in 6 30-minute skills sessions.
A clinical psychologist will deliver all of the sessions.
The main intervention goal is to provide dyads with resiliency skills to reduce emotional distress and prevent chronic distress.
|
The intervention will teach resiliency skills (mindfulness, coping, interpersonal communication, etc.) to the comatose patient's caregiver.
These sessions will take place in person or on Zoom, depending on the participant's preference.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Preliminary feasibility of recruitment
Time Frame: 0 weeks
|
We will assess the proportion of caregivers enrolled from the number of caregivers eligible.
|
0 weeks
|
|
Preliminary feasibility of assessments
Time Frame: Change from pre-test (0 weeks) to post-test (6 weeks).
|
We will assess the proportion of caregivers enrolled that completed all assessments.
|
Change from pre-test (0 weeks) to post-test (6 weeks).
|
|
Preliminary feasibility of adherence
Time Frame: Change from pre-test (0 weeks) to post-test (6 weeks).
|
We will assess the proportion of enrolled caregivers that complete 4 out of 6 sessions.
|
Change from pre-test (0 weeks) to post-test (6 weeks).
|
|
Preliminary feasibility of therapist fidelity
Time Frame: Change from pre-test (0 weeks) to post-test (6 weeks).
|
We will assess the number of sessions in which the therapist adhered 100% to the treatment manual based on a fidelity checklist.
|
Change from pre-test (0 weeks) to post-test (6 weeks).
|
|
Preliminary treatment satisfaction
Time Frame: post-test (6 weeks after session 1)
|
We will assess the proportion of enrolled caregivers that score above the midpoint on the Client Satisfaction Questionnaire-3.
Scores range from 3 to 12; higher values indicate greater satisfaction.
|
post-test (6 weeks after session 1)
|
|
Preliminary treatment credibility
Time Frame: post-test (6 weeks after session 1)
|
We will use the Credibility and Expectancy Questionnaire (CEQ) to assesses caregivers perceptions that the treatment will work after learning about the study.
Scores range from 3-27; higher ratings indicate more belief that the program is logical and will help with the intended outcome.
|
post-test (6 weeks after session 1)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hospital Anxiety and Depression Scale (HADS)
Time Frame: Change from pre-test (0 weeks) to post-test (6 weeks)
|
We will use the Hospital Anxiety and Depression Scale HADS, a 14-item measure that assesses symptoms of emotional distress (anxiety and depression).
The anxiety and depression sub-scale are each scored from 0-21, with higher scores indicating greater severity of symptoms.
Scores can be summed to create a global emotional distress score (0-42).
|
Change from pre-test (0 weeks) to post-test (6 weeks)
|
|
Posttraumatic Stress Disorder Checklist-5
Time Frame: Change from pre-test (0 weeks) to post-test (6 weeks)
|
Post-Traumatic Stress Disorder Checklist - 5; range 0-80, higher scores indicate greater posttraumatic stress
|
Change from pre-test (0 weeks) to post-test (6 weeks)
|
|
Cognitive and Affective Mindfulness Scale-Revised (CAMS-R)
Time Frame: Change from pre-test (0 weeks) to post-test (6 weeks)
|
Cognitive and Affective Mindfulness Scale-R (CAMS-R); 12-48, higher scores indicate greater perceived mindfulness
|
Change from pre-test (0 weeks) to post-test (6 weeks)
|
|
Measure of Current Status Part A (MOCS-A)
Time Frame: Change from pre-test (0 weeks) to post-test (6 weeks)
|
Measure of Current Status Part A (MOCS-A); 0-52; higher scores indicate greater perceived ability to cope
|
Change from pre-test (0 weeks) to post-test (6 weeks)
|
|
Toronto Mindfulness Scale-Trait (TMS-Trait)
Time Frame: Change from pre-test (0 weeks) to post-test (6 weeks)
|
Toronto Mindfulness Scale-Trait (TMS-Trait); 0-52, higher scores indicate greater perceived mindfulness (specifically curiosity and de-centering)
|
Change from pre-test (0 weeks) to post-test (6 weeks)
|
|
Enhancing Recovery in Coronary Heart Disease Social Support Instrument (ESSI)
Time Frame: Change from pre-test (0 weeks) to post-test (6 weeks)
|
Enhancing Recovery in Coronary Heart Disease Social Support Instrument (ESSI); the ESSI measures the participant's range of social support in their life.
Higher scores indicated higher levels of social support.
Total scores range from 8 to 34.
|
Change from pre-test (0 weeks) to post-test (6 weeks)
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2021P000423
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coma
-
Hospices Civils de LyonNot yet recruiting
-
Institut National de la Santé Et de la Recherche...Recruiting
-
University Hospital, ToulouseCompleted
-
Cairo UniversityHelwan University; Prince Sattam Bin Abdulaziz UniversityCompletedComa, Traumatic | Patients With Traumatic Brain InjuryEgypt
-
Centre Hospitalier Universitaire de BesanconTerminated
-
Akdeniz UniversityNot yet recruitingNursing Caries | Head Trauma | Traumatic Coma
-
RenJi HospitalXiangya Hospital of Central South University; Beijing Tiantan Hospital; The General... and other collaboratorsNot yet recruitingBrain Injuries, Traumatic | ComaChina
-
Dokuz Eylul UniversityUnknown
-
University of OxfordChittagong Medical College and HospitalCompleted
-
Children's Hospital at MontefioreRecruitingComa | Status EpilepticusUnited States
Clinical Trials on COMA-F
-
Massachusetts General HospitalNot yet recruitingBrain Injury | Coma | Emotional Distress | Resilience | Caregivers | Caregiver DistressUnited States
-
Hangzhou Normal UniversityCompletedMinimally Conscious State | Vegetative State
-
First Affiliated Hospital Xi'an Jiaotong UniversityAnkang Central HospitalRecruiting
-
Massachusetts General HospitalCompletedMuscle Weakness | Motor Activity | Muscle StrengthUnited States
-
Massachusetts General HospitalCompletedTraumatic Brain Injury | Disorder of ConsciousnessUnited States
-
Hangzhou Normal UniversityCompletedDisorder of Consciousness | Minimally Conscious State | Unresponsive Wakefulness SyndromeChina
-
I.R.C.C.S. Fondazione Santa LuciaRecruitingDisorder of ConsciousnessItaly
-
Jing WangCompletedMinimally Conscious State | Vegetative StateChina
-
Hangzhou Normal UniversityCompletedDisorder of Consciousness | Minimally Conscious StateChina